1 not yet recruiting, 1 withdrawn. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Not yet recruiting 1, Withdrawn 1 |
Follow apraclonidine: new trials by email Literature Review of apraclonidine trials Research Report on apraclonidine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Iopidine to Decrease Intraocular Pressure Rise After Injections Apraclonidine 1.0% ophthalmic solution - Macular Degeneration, Diabetic Retinopathy | Phase 4 | Not yet recruiting | Retina Consultants of Delmarva | 120 | 2026-10-01 | 2026-10-23 |
| Efficacy of Topical Apraclonidine for the Treatment of Ocular Synkinesis Apraclonidine - Synkinesis, Facial Nerve Palsy | Phase 4 | Withdrawn | University of Alabama at Birmingham | 2025-12-01 | 2024-07-19 |
Bell Palsy (1) · Diabetic Retinopathy (1) · Glaucoma (1) · Macular Degeneration (1) · Retinal Vein Occlusion (1) · Synkinesis (1)
Retina Consultants of Delmarva (1) · University of Alabama at Birmingham (1)
United States (1)